-
Pentoxifylline: From PDE Biology to Translation
2026-09-01
Pentoxifylline is more than a legacy circulation-support compound: it is a cAMP-modulating phosphodiesterase inhibitor that connects inflammatory signaling, monocyte adhesion, and translational assay design. This thought-leadership guide examines the evidence, workflow decisions, competitive positioning, and limitations that matter when developing Pentoxifylline-based research programs.
-
Sisomicin Activity Against Clinical Isolates
2026-09-01
Stewart and Bodey evaluated sisomicin against 565 clinical bacterial isolates and found activity broadly comparable to gentamicin and tobramycin, with stronger in vitro activity than kanamycin and butirosin against most gram-negative bacilli. The study provides a useful historical framework for interpreting aminoglycoside MIC distributions, cross-resistance, inoculum effects, and the limits of translating laboratory susceptibility into therapeutic conclusions.
-
ERCC1 Deficiency, p53, and Platinum Response
2026-08-31
Heyza and colleagues used CRISPR-Cas9-engineered lung cancer models to show that ERCC1 loss does not determine cisplatin sensitivity independently of p53 status. Their findings connect p53-dependent apoptosis, altered interstrand crosslink repair kinetics, and DNA-PKcs/BRCA1-associated tolerance mechanisms to the interpretation of ERCC1 as a platinum-response biomarker.
-
Masitinib (AB1010): KIT/PDGFR Workflow
2026-08-31
Masitinib (AB1010), SKU A2942, provides a DMSO-compatible research tool for investigating KIT, PDGFRα, PDGFRβ, selected KIT mutants, and mast-cell responses. It is intended for controlled biochemical, cellular, and preclinical workflows, not direct aqueous or ethanol-based dosing, broad-spectrum kinase profiling, or clinical treatment decisions.
-
JNK-IN-7: Selective JNK Inhibitor for Apoptosis
2026-08-30
JNK-IN-7 is a selective JNK inhibitor with nanomolar reported activity against JNK1, JNK2, and JNK3. Its covalent JNK2 mechanism supports mechanistic studies of c-Jun phosphorylation, MAPK signaling pathway research, apoptosis, and innate immune signaling modulation.
-
Selonsertib (GS-4997) in Renal Injury Research
2026-08-29
Selonsertib (GS-4997) provides a selective, ATP-competitive way to interrogate ASK1-driven oxidative stress, inflammation, and fibrosis in kidney models. This workflow-focused guide translates lupus nephritis findings into practical HK-2 cell, signaling, and animal-study designs while separating published parameters from optimization recommendations.
-
Cand2 Links Ubiquitination, Autophagy, and Fungal Virulence
2026-08-28
The reference study identifies MoCand2 as a conserved fungal inhibitor of Cullin-RING ligase activity and defines how it connects ubiquitination with autophagy and rice blast pathogenicity. Its genetic, biochemical, and infection assays provide a framework for separating proteostasis control from downstream defects in growth, sporulation, stress resistance, and host infection.
-
Ibrexafungerp (MK 3118) Research Workflows
2026-08-28
Ibrexafungerp (MK 3118) supports antifungal studies spanning resistant Candida, acidic vaginal conditions, and translational infection models. This workflow-focused guide explains assay setup, FKS-informed interpretation, comparative testing, and practical troubleshooting.
-
MCC950 sodium: Reliable NLRP3 Assay Design
2026-08-27
Learn how MCC950 sodium (SKU B7946) can help researchers distinguish NLRP3-driven inflammatory injury from nonspecific changes in cell viability and metabolism. This scenario-based guide covers model selection, protocol parameters, data interpretation, and practical product-selection criteria.
-
Ac-YVAD-CMK: Decoding Kupffer Cell Inflammation
2026-08-27
Ac-YVAD-CMK provides a mechanistic way to separate caspase-1-dependent cytokine maturation from TMEM16F-mediated membrane repair in Kupffer cells. This article translates the Listeria liver-inflammation study into a practical assay and interpretation framework for pyroptosis research.
-
Isochlorogenic Acid A Hydrogel Wound Repair Study
2026-08-26
A 2026 study developed an amylopectin/carboxymethyl chitosan hydrogel containing Isochlorogenic acid A/Fe3+ co-assembled nanoparticles to address solubility, stability, infection, and repair challenges in chronic wounds. The composite showed antibacterial activity, favorable material properties, enhanced cell migration, and improved wound healing with changes in inflammatory and vascularization-associated markers.
-
Tranexamic Acid for Fibrinolysis Research
2026-08-26
Use Tranexamic Acid to connect plasmin inhibition with reproducible clot-stability, neutrophil-adherence, and biomaterial assays. This workflow also shows how an antifibrinolytic agent can be evaluated separately from antibacterial components in advanced wound-dressing prototypes.
-
Ac-YVAD-CMK in Kupffer Cell Inflammation Studies
2026-08-25
Ac-YVAD-CMK provides a mechanistic way to test whether caspase-1-dependent cytokine maturation and pyroptosis contribute to liver inflammation during bacterial challenge. Its greatest value in TMEM16F research is not as a membrane-repair substitute, but as a precision perturbation that separates inflammatory signaling from physical Kupffer cell injury.
-
iMSC Exosomes Reprogram Macrophages in IDD
2026-08-25
This study identifies a reciprocal inflammatory circuit between senescent nucleus pulposus cells and macrophages in intervertebral disc degeneration. It further shows that exosomes from human iPSC-derived mesenchymal stem cells deliver miR-100-5p, suppress mTORC1-linked glycolytic programming, and shift macrophages toward an anti-inflammatory state, with therapeutic effects reproduced in a rat model.
-
Nitrocefin: From Signal to Resistance Strategy
2026-08-24
Nitrocefin is more than a rapid color-change reagent: it is a functional bridge between β-lactamase mechanism, resistance profiling, and translational assay strategy. This article explains how to use a chromogenic cephalosporin substrate to interpret enzyme activity, investigate GOB-38 biology, and design stronger β-lactamase inhibitor screening workflows.